Molecular diagnostics clinical utility strategy: a six-part framework.

Area of Science:

• Health economics
• Regulatory science
• Molecular diagnostics

Background:

• Clinical utility of molecular tests influences regulatory and payer decisions.
• The definition of clinical utility remains a subject of debate.
• Demonstrating value is key for test adoption.

Purpose of the Study:

• To clarify the definition of clinical utility for molecular diagnostic tests.
• To propose a framework for assessing and communicating test value.
• To bridge communication gaps between test developers and evaluators.

Main Methods:

• Literature review on clinical utility definitions.
• Development of a six-part framework for value proposition assessment.
• Analysis of regulatory and payer decision-making processes.

Main Results:

• Clinical utility is defined by impact on clinical outcomes.
• A structured framework can build confidence in a test's value.
• The proposed framework aids regulatory and payer evaluations.

Conclusions:

• The definition of clinical utility is straightforward and outcome-based.
• A systematic approach is needed to prove the clinical value of diagnostic tests.
• The proposed framework facilitates evidence generation for regulatory and reimbursement decisions.